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Background/aim: Continuous oxygen reserve index (ORI) measurement with multiple wave pulse co-oximetry is a noninvasive
measurement. The decrease in the ORI trend provides a prediction for the development of hypoxemia and provides information on
hyperoxia. Our aim is to determine the effect of ORI-guided oxygen titration on hyperoxemia-mediated morbidity.
Materials and methods: Consecutive 120 ASA I-III patients, 18–70 years of age, without severe obstruction or restriction, undergoing
one lung ventilation (OLV), were included in the study. Patients were divided into 4 groups. Oxygen titration without ORI monitoring
with low-flow anesthesia (1 L/min, Group 1, n = 25) and high-flow anesthesia (4 L/min, Group 2, n = 28). Oxygen titration by ORI
monitoring with low flow anesthesia (1 L/min, Group 3, n = 25) and high flow anesthesia (4 L/min, Group 4, n = 25). FiO2 increased up
to 100% if necessary. OLV time, duration of surgery and anesthesia, FiO 2 applied during OLV, oxygen application time (T) over 60%,
vital signs, hospital and ICU stay time, and complications were recorded.
Results: There was a statistically significant difference in terms of FiO2 used during OLV (p < 0.05). There was no difference in ORI
values (p < 0.05). In Group 3, both PaO2 and SpO2 were significantly lower than the others both before and during OLV. There was no
significant difference in terms of ORI parameters between low flow and high flow anesthesia groups. There was a strong, positive
correlation between the duration of hospital stay and FiO2 used above 80% during OLV.
Conclusion: We concluded that ORI-guided thoracic anesthesia may reduce hospital stay and increase patient safety.
Key words: Oxygen reserve index, thoracic surgery, one lung ventilation, low flow anesthesia

1. Introduction
Oxygen saturation (SpO2) is measured by pulse oximetry
during intraoperative period. Unless there is a significant
decrease in PaO2 (arterial oxygen partial pressure), SpO2
may not always adequately reflect the reduction in
oxygenation. Multi-wave pulse co-oximeter (Masimo,
Irvine, CA, USA) and oxygen reserve index (ORI)
measurement offers a noninvasive way of providing realtime visibility to oxygenation status in moderate
hyperoxic range (PaO2 of approximately 100 to 200 mm
Hg) [1]. ORI provides additional data on hyperoxia when
SpO2 is greater than 98% [2]. The harmful effects of
hyperoxemia include the formation of reactive oxygen
compounds, cell damage, inflammatory pathway
activation and cell death [3]. Absorption atelectasis,
prolongation of hospital stays, and poor neurological
activity in discharge have been reported previously [4].
One lung ventilation (OLV) is a technique used for
single lung isolation to facilitate a wide variety of
procedures on ipsilateral thoracic or mediastinal
structures as well as to provide lung isolation. In the
studies conducted to date, the importance of
intraoperative hypoventilation, hypoxemia, ventilation
perfusion disorders that may occur during OLV has been

mentioned [5,6]. Immediately after the onset of OLV,
arterial
oxygenation
and
saturation
decrease.
Accordingly, hypoxic pulmonary vasoconstriction (HPV)
occurs. In order to keep SpO2 over 90% during this
process, 100% oxygen (O2) is recommended [7].
Therefore, the patients are exposed to hyperoxemia.
This study aims to protect patients from the harmful
effects of hyperoxemia with a noninvasive probe during
OLV. The primary outcome of this study is to compare the
mean FiO2 (the fraction of inspired oxygen) values in
patients undergoing thoracic surgery with and without
ORI monitoring. The secondary outcome is to compare the
duration of 100% O2 use.
2. Materials and methods
The study was approved by the Human Research Ethics
Committee of our University Medical School. Written
informed consent was obtained from every patient during
the preoperative visit. The study was registered in UMIN
Clinical Trials Registry (UMIN000038068). This
prospective, randomized, cross-sectional study included
patients with lung tumors between September 2018 and
September 2019. Inclusion criteria were age between 18
and 80-year-old patients undergoing elective thoracic
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surgery requiring OLV. Exclusion criteria were the refusal
to participate and a history of pulmonary resection.
Patients were divided into 4 groups. Oxygen titration
in the absence of ORI monitoring with low-flow anesthesia
(1 L/min, Group 1, n = 25) and normal-flow anesthesia (3–
4 L/min, Group 2, n = 28). Oxygen titration by ORI
monitoring with low flow anesthesia (1 L/min, Group 3, n
= 25) and normal flow anesthesia with ORI monitoring (3–
4 L/min, Group 4, n = 25). Randomization was performed
by opaque sealed envelopes.
After the patients were admitted to the operating
theatre, SpO2, electrocardiogram (ECG), and noninvasive
blood pressure were measured routinely. Anesthesia was
induced with propofol, 2–3 mg/kg, rocuronium, 0.6
mg/kg, and fentanyl, 2–3 mcg/kg. A 20 G, radial artery
catheter was placed and connected to a disposable
pressure transducer following the induction of anesthesia.
Tracheal intubation was performed using a left
Robertshaw double lumen tube. We confirmed the
position by a flexible 4.2 mm fiberoptic bronchoscope.
Anesthesia maintenance was achieved with sevoflurane
or desflurane, and remifentanil 0.25 mcg/kg/h.
In addition to standard follow-up parameters, ORI,
noninvasive and continuous hemoglobin (SpHb), peak
variable index (PVI), perfusion index (PI), and SpOc
(oxygen contusion) were continuously monitored in
Group 3 and Group 4. Patients' SpO2, arterial oxygen
partial pressure (PaO2), ORI, PVI, PI, and SpOc values were
recorded and the correlation between them were
determined on the continuous graphs. ORI values were
measured with the Rainbow R1 25-L probe (Irvine, CA,
USA). Patients were monitored with the Masimo low noise
cabled sensors (M-LNCS) probe, which is attached to the
Radical-7 Pulse CO-Oximeter device for the measurement
of PVI. The duration of surgery, anesthesia, OLV, and total
100% oxygen application time were recorded. The
titration of oxygen was performed manually according to
the SpO2 and PaO2 values in Groups 1 and 2.
In the study groups oxygen titration was performed
according to PaO2, SpO2, ORI, and SpOc values. Routine
blood gas follow-ups were taken before achieving OLV, at
the 15th min of OLV, 45th min of OLV. Routinely, patients
were ventilated with 50% FiO2 (50% oxygen + 50% air
mixture, 1 L/min fresh gas flow) after induction. FiO2 was
increased to 60% when OLV is applied. Afterwards FiO2
was increased to 70%, 80%, and 100% concentration if
necessary. Hemodynamic variables were recorded
including heart rate and blood pressure. The incidence of
thromboembolic complications, arrhythmia, pneumonia,
the duration of hospital, and intensive care unit stay were
recorded.
2.1. Data analysis
Study data was processed using IBM SPSS Statistics for
Windows, v: 22.0 (Armonk, NY, IBM Corp.) The
distribution of the variables was analyzed using the
Kolmogorov–Smirnov test. The Mann–Whitney U test was
used to investigate the qualitative data. The Spearman’s
correlation analysis was used to examine correlation
2414

between the variables. For binary comparisons, One-way
ANOVA test was used for the numerical data that
conformed to the normal distribution, and the Mann–
Whitney-U test was used for those who did not comply. As
a 4 group comparison test, One-way ANOVA was used for
the data with normal distribution and the Kruskal–Wallis
test was used for those who did not comply. Chi-square
test was used to analyze discrete variables. A value of p <
0.05 was considered statistically significant.
2.2. Sample size calculation
Based on a 25% reduction in the use of O2 with > 60% FiO2
during OLV, it was necessary to take a total of 100 patients
in this study. At a significance level of 95% the standard
effect size was taken as 0.65 with a power of 90%.
Therefore, a minimum of 25 patients per group were
enrolled.
3. Results
A total of 103 patients aged 18 to 79 years (54.53 ± 14.46),
were included in the study (Table 1). Of these patients, 27
(26.2%) were female and 76 (73.8%) were male. None of
the patients were excluded. The duration of OLV with
>%60 FiO2 was significantly lower in ORI study groups:
67.6 ± 97.5 min, 97.32 ± 99.7 min, 39.2 ± 74.1 min and 22.4
± 49.4 min in Groups 1–4, respectively (p = 0.003). Mean
FiO2 values during OLV were 71.6 ± 12.25%, 74.64 ±
16.66%, 62.8 ± 13.08% and 56.4 ± 11.5% in Groups 1– 4,
respectively (p = 0.001).
The types of surgeries were VATS biopsy, VATS
lobectomy, and VATS wedge resection (p = 0.085). There
was no statistically significant difference between groups
in terms of hemodynamic parameters (Table 2). In Group
3, both PaO2 and SpO2 were significantly lower than the
others both before and during OLV (Table 3). Other blood
gas parameters were similar.
There was no significant difference in terms of ORI
parameters between low flow and high flow anesthesia
groups. There was a strong, positive correlation between
the duration of hospital stay and FiO2 used above 80%
during OLV (Table 4, p < 0.001). There was no significant
relationship between the duration of intensive care unit
stay and OLV with above 80% FiO2. No complication was
recorded including thromboembolism, arrhythmia or
pneumonia.
4. Discussion
In this study, the ORI monitor was associated with lower
mean FiO2 values during OLV. With the addition of ORI
monitor, lower PaO2 values were recorded. A strong
significant correlation was found between the duration of
OLV with above 80% FiO2 and the duration of hospital
stay.
The hypoxic pulmonary vasoconstriction during OLV
is characteristically biphasic. It is activated within the first
few seconds in its first phase and reaches its maximum
within 15 min. The second phase begins 30–40 min later
and makes a late peak at the second hour. The maximal
hypoxic pulmonary vasoconstriction response during OLV
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Table 1. Patients’ demographic and clinical characteristics.
Group 1

Group 2

Group 3

Group 4

(n = 25)

(n = 28)

(n = 25)

(n = 25)

Sex

8(28.6%)

8(32%)

Female

2(8%)

Male

23(92%)

20(71.4%)

16(64%)

17(68%)

Age (years)

49.48 ± 18.7

58.82 ± 12.73

53.52 ± 12.19

55.8 ± 12.54

0.207b

BMI (kg/m2)

25.37 ± 4.81

27.18 ± 4.54

28.18 ± 5.49

27.18 ± 4.04

0.317b

3(12%)

0(0%)

ASA2

22(88%)

21(75%)

21(84%)

20(80%)

ASA3

0(0%)

7(25%)

4(16%)

4(16%)

Reoperation

1(4%)

1(3.6%)

0(0%)

0(0%)

0.586c

Complication

3(12%)

2(7.1%)

3(12%)

2(8%)

0.898c

Duration of surgery (min)

181.25 ± 79.58

204.82 ± 96.69

194.4 ± 100.8

199.4 ± 89.4

0.824a

Duration of anesthesia (min)

230 ± 83

255.43 ± 98.39

239.8 ± 103.2

257.8 ± 94.1

0.696a

Duration of hospital stay (days)

6.56 ± 3.03

6.21 ± 2.63

6.44 ± 3.44

5.52 ± 1.64

0.734b

Duration of OLV (min)

121.9 ± 72.41

146.79 ± 82.7

135.4 ± 87.6

156.6 ± 80.2

0.364b

OLV with >%60 FiO2 (min)

67.6 ± 97.5

97.32 ± 99.7

39.2 ± 74.1

22.4 ± 49.4

0.003*bA

Mean FiO2 during OLV (%)

71.6 ± 12.25

74.64 ± 16.66

62.8 ± 13.08

56.4 ± 11.5

0.001*bB

Perioperative colloid (mL)

350 ± 399

448 ± 491

280 ± 265

402 ± 441

0.750b

Perioperative crystalloid (mL)

1096 ± 414

1285 ± 656

1196 ± 616

1288 ± 447

0.524b

ASA
ASA1

9(36%)

p

0(0%)

0.110c

1(4%)
0.053c

Chi-square test: values are given as frequency (percentage).
ᵇ Kruskal–Wallis H test: values are given as mean ± standard deviation.
ᵃ One-way Anova test: values are given as mean ± standard deviation.
*p < 0.05 statistically significant.
A = G2 vs. G3, p = 0.005; G2 vs. G4, p = 0.001.
B = G1 vs. G3, p = 0.019; G1 vs. G4, p = 0.001; G2 vs. G3, p = 0.006; G2 vs. G4, p = 0.001; G3 vs. G4, p = 0.021.
Group 1: Low-flow anesthesia and oxygen titration without ORI monitoring.
Group 2: Normal-flow anesthesia and oxygen titration without ORI monitoring.
Group 3: Low-flow anesthesia and oxygen titration with ORI monitoring.
Group 4: Normal-flow anesthesia and oxygen titration with ORI monitoring.
c

reduces blood flow to the nondependent lung by 50% [6].
In this process, increasing the FiO2 up to 1.0% and alveolar
recruitment maneuvers are among the initial treatment
options. However, high FiO2 is associated with hyperoxiainduced oxidative acute lung injury [8]. Characteristics of
injury are increased inflammatory-cell counts,
reabsorption atelectasis, and raised pulmonary
permeability, which may result in necrosis. The FiO 2
should be reduced as soon as possible. For this purpose,
continuous monitoring is not possible when the analysis
of blood gas parameters is intermittent. The values of the
patient are recorded noninvasively with ORI
measurements which is a unit-less scale. When the PaO2
value exceeds 100 mmHg, it exceeds 0.1. In this way it is

possible to protect the patient from the harmful effects of
hyperoxia. ORI is a relative indicator of changes in PaO2 in
the hyperoxic range between 100 to 200 mmHg.
The use of ORI monitor is becoming increasingly
common during OLV. It has been used for the
determination of hypoxia however, studies on hyperoxia
are extremely limited [9]. 1.0% FiO2 is often used during
OLV. In our study, mean FiO2 during OLV was 62.8 ±
13.08% and 56.4 ± 11.5% in patients undergoing ORI
monitor. The values were 71.6 ± 12.25% and 74.64 ±
16.66% in traditionally monitored patients and were
significantly higher. This result indicates that the risk of
hyperoxia will be lower in patients undergoing the ORI
monitor.
2415
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Table 2. Hemodynamic parameters, SpO2, etCO2 and temperature variables of patients before and during OLV.
Group 1

Group 2

Group 3

Group 4

(n = 25)

(n = 28)

(n = 25)

(n = 25)

MAP (mmHg)

73.87 ± 13.67

79.82 ± 10.36

83.08 ± 16.4

82.64 ± 20.24

0.176b

Heart rate (beat/min)

68.72 ± 12.71

74.57 ± 14.95

73.4 ± 13.37

87.4 ± 99.73

0.265b

SpO2 (%)

99.08 ± 1.85

99.46 ± 0.69

98.16 ± 1.72

98.6 ± 1.41

0.006*bA1

etCO2 (mmHg)

34.68 ± 3.57

34.54 ± 3.99

33.58 ± 3.68

34.25 ± 3.45

0.763b

Temperature (°C)

35.64 ± 1.0

35.78 ± 0.68

35.80 ± 0.60

35.79 ± 0.72

0.960b

15 min after OLV

Group 1

Group 2

Group 3

Group 4

(n = 25)

(n = 28)

(n = 25)

(n = 25)

MAP (mmHg)

73.08 ± 11.85

75.96 ± 8.58

77.56 ± 11.19

74.84 ± 8.61

0.636a

Heart rate (beat/min)

72.44 ± 11.72

74.14 ± 12.25

74.56 ± 15.98

68.64 ± 10.64

0.346a

SpO2 (%)

97.72 ± 5.37

97.46 ± 1.77

94.84 ± 11.8

96.48 ± 2.2

0.001*bA2

etCO2 (mmHg)

33.68 ± 4.05

34.03 ± 3.74

38.21 ± 12.63

34.64 ± 3.56

0.146b

Temperature (°C)

35.39 ± 1

35.44 ± 0.27

35.63 ± 0.76

35.35 ± 0.79

0.719b

Group 1

Group 2

Group 3

Group 4

(n = 25)

(n = 28)

(n = 25)

(n = 25)

MAP (mmHg)

73.54 ± 9.04

79.39 ± 9.52

74.19 ± 12.15

77.63 ± 7.35

0.071b

Heart rate (beat/min)

69.63 ± 12.15

74 ± 11.43

70 ± 11.04

65.83 ± 7.94

0.065a

SpO2 (%)

98.21 ± 1.67

97.36 ± 1.95

95.73 ± 2.41

97.46 ± 2.23

0.004*b

etCO2 (mmHg)

33.21 ± 4.76

33.36 ± 3.55

33.68 ± 3.18

33.92 ± 3.64

0.902b

Temperature (°C)

35.3 ± 0.99

35.23±0.67

35.27 ± 0.60

35.2 ± 0.77

0.968a

At the end of OLV

Group 1

Group 2

Group 3

Group 4

(n = 25)

(n = 28)

(n = 25)

(n = 25)

MAP (mmHg)

73.77 ± 12.9

79.71 ± 10.06

81.27 ± 9.06

80.25 ± 8.08

0.135b

Heart rate (beat/min)

70.78 ± 12.26

75.61 ± 11.91

73.55 ± 13.45

67.33 ± 6.85

0.063a

SpO2 (%)

98.57 ± 2.13

98.86 ± 1.65

97.77 ± 2.16

98.54 ± 1.22

0.125b

etCO2 (mmHg)

33.43 ± 5.18

34.57 ± 9.89

33.23 ± 3.25

34.71 ± 3.76

0.457b

Temperature (°C)

35.41 ± 1.0

35.37 ± 0.77

35.15 ± 0.65

35.06 ± 0.75

0.390a

Before OLV

45 min after OLV

*p < 0.05 Statistically significant between groups.
ᵃ One-way Anova test: values are given as mean ± standard deviation.
ᵇ Kruskal–Wallis H test: values are given as mean ± standard deviation.
A1 = G1 vs. G3, p = 0.012; G2 vs. G3, p = 0.003; G2 vs. G4, p = 0.021.
A2 = G1 vs. G3, p = 0.001; G2 vs. G3, p = 0.001; G3 vs. G4, p = 0.013.
Group 1: Low-flow anesthesia and oxygen titration without ORI monitoring.
Group 2: Normal-flow anesthesia and oxygen titration without ORI monitoring.
Group 3: Low-flow anesthesia and oxygen titration with ORI monitoring.
Group 4: Normal-flow anesthesia and oxygen titration with ORI monitoring.
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Table 3. The comparison of blood gas parameters.
Before OLV

Group 1

Group 2

Group 3

Group 4

p

(n = 25)

(n = 28)

(n = 25)

(n = 25)

Ph

7.42 ± 0.4

7.41 ± 0.5

7.41 ± 0.05

7.39 ± 0.04

0.557b

CO2 (mmHg)

39.8 ± 4.9

39.3 ± 4.2

40.3 ± 4.8

39.67 ± 5.09

0.821b

PaO2 (mmHg)

236 ± 79

190 ± 52

166 ± 75

175.5 ± 47.8

0.001*bA1

SpO2 (%)

99.5 ± 0.7

99.6 ± 0.6

98.6 ± 1.2

99.01 ± 0.9

0.001*bB1

Base excess

1.64 ± 2.31

0.53 ± 2.4

0.82 ± 2.5

0.16 ± 2.7

0.199a

Lactate

1.12 ± 0.4

1.24 ± 0.6

1.24 ± 0.4

1.4 ± 0.6

0.596b

15 min after OLV

Group 1

Group 2

Group 3

Group 4

p

(n = 25)

(n = 28)

(n = 25)

(n = 25)

Ph

7.4 ± 0.04

7.18 ± 1.1

7.4 ± 0.04

7.39 ± 0.05

0.476b

CO2 (mmHg)

39.75 ± 4.89

40.89 ± 4.9

42.8 ± 5.6

40.32 ± 4.2

0.282b

PaO2 (mmHg)

135.6 ± 72.1

116.5 ± 53.3

93.0 ± 36.7

97.1 ± 24.5

0.071b

SpO2 (%)

97.6 ± 1.9

97.5 ± 2.3

95.2 ± 3.2

96.5 ± 2.6

0.006*bA2

Base excess

1.05 ± 2.3

0.5 ± 2.6

1.2 ± 2.4

0.6 ± 3.1

0.743a

Lactate

1.06 ± 0.3

1.24 ± 0.5

1.26 ± 0.4

1.2 ±0.5

0.379b

45 min after OLV

Group 1

Group 2

Group 3

Group 4

p

(n = 25)

(n = 28)

(n = 25)

(n = 25)

Ph

7.41 ± 0.03

7.4 ± 0.04

7.39 ± 0.04

7.39 ± 0.05

0.787b

CO2 (mmHg)

40.74 ± 3.6

41.24 ± 9.93

41.66 ± 4.71

41.08 ± 9.75

0.221b

PaO2 (mmHg)

142.7 ± 81.3

116.9 ± 53.2

94.4 ± 39.3

118.2 ± 46.1

0.014*bA3

SpO2 (%)

97.8 ± 2.4

97.6 ± 1.8

95.8 ± 2.3

96.9 ± 2.1

0.004*bB2

Base excess

0.81 ± 2.63

0.56 ± 2.86

0.97 ± 3.13

0.17 ± 2.9

0.368b

Lactate

1.13 ± 0.38

1.21 ± 0.62

1.36 ± 0.4

1.31 ± 0.6

0.159b

At the end of OLV

Group 1

Group 2

Group 3

Group 4

p

(n = 25)

(n = 28)

(n = 25)

(n = 25)

Ph

7.4 ± 0.04

7.4 ± 0.06

7.4 ± 0.03

7.38 ± 0.06

0.597b

CO2 (mmHg)

40.25 ± 4.2

38.4 ± 4.69

39.9 ± 5.1

41.73 ± 10.1

0.406b

PaO2 (mmHg)

164.5 ± 67.6

163.2 ± 63.8

120.1 ± 47.6

152.87 ± 68.7

0.045*bA4

SpO2 (%)

98.4 ± 1.7

98.4 ± 1.7

94.6 ± 12.9

98.18 ± 1.46

0.059b

Base excess

0.75 ± 2.1

0.21 ± 2.6

0.15 ± 2.6

0.5 ± 3.45

0.436a

Lactate

1.27 ± 0.35

1.67 ± 0.81

1.52 ± 0.8

1.53 ± 0.6

0.423b

A1 = G1-G2, p = 0.023 vs. G1-G3, p = 0.001 vs. G1-G4, p = 0.003 vs. G2-G3, p = 0.030.
A2 = G1-G3, p = 0.002 vs. G2-G3, p = 0.004.
A3 = G1-G3, p = 0.005 vs. G2-G3, p = 0.027 vs. G3-G4, p = 0.009.
A4 = G1-G3, p = 0.019 vs. G2-G3, p = 0.014.
B1 = G1-G3, p = 0.001 vs. G1-G4, p = 0.028 vs. G2-G3, p = 0.001 vs. G2-G4, p = 0.018.
B2 = G1-G3, p = 0.002 vs. G1-G4, p = 0.029 vs. G2-G3, p = 0.005.
*p < 0.05 statistically significant between groups.
Group 1 Low-flow anesthesia and oxygen titration without ORI monitoring.
Group 2: Normal-flow anesthesia and oxygen titration without ORI monitoring.
Group 3: Low-flow anesthesia and oxygen titration with ORI monitoring.
Group 4: Normal-flow anesthesia and oxygen titration with ORI monitoring.

Arterial blood gas analysis is essential for the
management of patients. However, it is not a continuous
monitoring method and besides takes a long time. We
obtained real time data with the ORI monitor. Thus it was
possible to detect changes in pulmonary function. As
Campos and Sharma [10] mentioned, ORI cannot replace
arterial blood gases analysis, however it is useful to assess

oxygenation. In groups without ORI monitors, the FiO 2
was significantly higher than 80%. Moreover, in our study,
it was revealed that these patients had a longer hospital
stay.
Koishi et al. [11] showed in their 15 subjects that ORi
and PaO2 were highly correlated during OLV. However, in
13 of the 15 cases, PaO2 was >240 mmHg at the start of
2417
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Table 4. Multivariate analysis of outcomes.
Correlations

OLV
80% O2

Pearson correlation

OLV
%80 O2
1

Sig. (2-tailed)

ICU stay

Hospital stay

0.069

0.315

0.488

0.001

Correlation is significant at the 0.01 level (2-tailed).**

OLV. Applegate et al. [12] concluded that when SpO2 is
>98%, ORI can distinguish PaO2 between 100 and 150 mm
Hg. The main difference of our study was the prevention
of patients from hyperoxemia with the ORI monitor. The
harmful effects of oxygen were eliminated by titrating the
oxygen. There was a strong, positive correlation between
the duration of hospital stay and FiO2 used above 80%
during OLV. There was no significant relationship
between the duration of Intensive Care Unit stay and OLV
with above 80% FiO2.
Exaggerated perioperative inflammatory response in
patients undergoing lung resection surgery has been
shown to potentially increase the risk of postoperative
pulmonary complications [6]. Also, patients undergoing
thoracic surgery are at risk of hypoxemia and hypercarbia
due to their existing disease. Besides one lung ventilation
may cause ventilation perfusion rate changes and
devastating effects due to mechanical ventilation [13]. In
the present study we revealed that low flow anesthesia
can be safely used during one lung ventilation. Using the
ORI monitor, we had no complications.
4.1. Limitations
In this study, malignant and benign patients were studied
together. The fact that only patients with malignancy were
not included in the study might have had an impact on the
length of stay in the hospital or ICU. This was the most

important limitation of the study. Studying in larger
sample size, might have increased the reliability of the
study.
4.2. Conclusion
The adjustment of Ori with peripheral oxygen saturation
and blood gas analysis demonstrated that hyperoxemia
could be prevented during OLV in patients under low flow
or high flow anesthesia. We concluded that ORI-guided
thoracic anesthesia may reduce hospital stay and increase
patient safety.
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